Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of HIV medicines for outpatient COVID-19
RBR-6wgwxsyPhase 2Not yet recruiting
- Sponsor
- Hospital das Clínicas da UFPE
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of atazanavir, ritonavir and doxycycline in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Hospital das Clínicas da UFPE. Planned start Apr 2022; status: not yet recruiting.
02
Drugs
atazanavirritonavirdoxycycline
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on RBR-6wgwxsy.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6wgwxsy.